|
肿瘤用户：肿瘤瞭望读者
|
时间：2026/1/25 23:28:43
|
查看评论对象
|
sosopdf
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2026/1/6 17:43:24
|
查看评论对象
|
Dear Colleagues,
we are pleased to invite you to browse the medical library of the Lactology Foundation, in which we have collected from the ocean of medical literature only the greatest medical bestsellers, which you can use under the terms of the shared reading license.
shop.toxylact.com/product-category/medical-books/
A Shared Reading License for e-books is a type of digital license that allows multiple users to access and read an e-book under specific conditions set by the publisher or distributor. Unlike traditional ownership or single-user licenses, this model enables shared access while maintaining control over distribution and usage.
Key Features of a Shared Reading License:
- Limited Concurrent Access – The license may restrict the number of users who can read the e-book simultaneously.
- Time-Limited or Subscription-Based – Access may be granted for a specific period rather than permanent ownership.
- Digital Rights Management (DRM) – The e-book may be protected by DRM technology to prevent unauthorized sharing or copying.
- Library and Institutional Use – Often used in libraries, educational institutions, or corporate environments to allow multiple readers to access the content legally.
- Lending and Borrowing – Some shared reading licenses permit users to "check out" the book for a certain duration, similar to a physical library system.
This model helps balance accessibility with copyright protection, ensuring fair use while preventing piracy and unauthorized distribution.
We are confident that you will like our selection of medical literature, as we want to assure you that we are increasing the volume of books offered monthly.
All proceeds from this activity of ours are directed towards the development of our toxico-lactological database TOXILACT, which analyzes the toxicity of breast milk if the mother takes medications during her lactation period.
toxylact.com
Sincerely
Dr. Dimitar Kehayov
Burgas
Bulgaria
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:40
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:39
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:36
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:35
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:33
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:32
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:29
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:28
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:26
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:24
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:23
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:21
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:20
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:18
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:16
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:14
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:13
|
查看评论对象
|
nqxN
|
|
|
|
肿瘤用户：肿瘤瞭望读者
|
时间：2025/12/24 21:14:11
|
查看评论对象
|
nqxN
|
|
|
